Anti-NPM1 autoantibodies are potential biomarkers for the immunodiagnosis of HCC due to the low positive rate in LC, CH, SLE and normal individuals and the higher positive rate in HCC patients. Here, NPM1 is linked to systemic lupus erythematosus.